Inceptive
Latest round
- Series A
Last raised
- Sep 2023
Total raised
- $100M
Investors
- 4
About Inceptive
Based in California, US, and founded in 2021 by Jakob Uszkoreit, Inceptive Nucleics, Inc. is a biotechnology company that develops software solutions to help medical professionals to design novel medicines and biotechnologies. As of 2023, the company operates from locations in Palo Alto, US, and Berlin, Germany. The firm develops an AI (Artificial Intelligence)- powered biological software that helps researchers to design, create and test unique mRNA sequences that help in the development of novel medicines and biotechnologies.
Who invested in Inceptive
4 investors across 1 round
See all investors in Inceptive
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 6, 2023
Amount
$100M
Investors
Questions about Inceptive
Who invested in Inceptive?
Inceptive has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Inceptive raised?
Inceptive has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Inceptive last raise money?
Inceptive's most recent round on record is a Series A, in Sep 2023.
What does Inceptive do?
Based in California, US, and founded in 2021 by Jakob Uszkoreit, Inceptive Nucleics, Inc.
Where is Inceptive headquartered?
Inceptive is headquartered in Palo Alto, US.
Which VCs invest in companies like Inceptive?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Inceptive's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Inceptive? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.